Brain tumor MRI study pulled before it started
NCT ID NCT06648473
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to check how consistent MRI scans are in people with a slow-growing brain tumor (IDH1-mutant low-grade glioma) who are taking the drug ivosidenib. The goal was to improve how doctors measure tumor changes over time. However, the study was withdrawn before any participants were enrolled, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOW GRADE GLIOMA OF BRAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New camera could help surgeons see hidden brain tumors
- Patients' voices heard: comparing brain tumor treatments through their eyes
- Laser zaps brain tumors in kids without open surgery
- Can we stop these cancer drugs without the tumor coming back?
- Scientists map Brain's electrical response during tumor surgery
- New PET-MRI tracer could sharpen view of Kids' brain tumors